Skip to content

Clinical trials

Gastrointestinal Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Country / region: South Korea Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20061
20111
20121
20131
20144
20161
20173
20193
20205
20211
20224
20231
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting7
Active, not recruiting6
Terminated4
Unknown status4
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Pfizer2
Revolution Medicines, Inc.2
Samsung Medical Center2
Aesculap AG1
Anthos Therapeutics, Inc.1
AstraZeneca1
Bayer1
BicycleTx Limited1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms34
Colorectal Neoplasms12
Stomach Neoplasms10
Neoplasms9
Carcinoma, Non-Small-Cell Lung8
Gastrointestinal Diseases6
Neoplasms by Site6
Biliary Tract Neoplasms5
Digestive System Neoplasms5
Endometrial Neoplasms5

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.